Area of research
Epidemiology · Hematology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Multiple Myeloma Research and Treatments, Diet, Metabolism, and Disease, and Diet and metabolism studies.
Pre-Clinical Assessment of SAR442257, a CD38/CD3xCD28 Trispecific T Cell Engager in Treatment of Relapsed/Refractory Multiple Myeloma
Resolving therapy resistance mechanisms in multiple myeloma by multiomics subclone analysis
Resolving the spatial architecture of myeloma and its microenvironment at the single-cell level
Cognitive Alterations in Old Mice Are Associated with Intestinal Barrier Dysfunction and Induced Toll-like Receptor 2 and 4 Signaling in Different Brain Regions
OA-23 Resolving therapy resistance mechanisms in multiple myeloma by multi-omics subclone analysis
Inhibiting PI3K–AKT–mTOR Signaling in Multiple Myeloma-Associated Mesenchymal Stem Cells Impedes the Proliferation of Multiple Myeloma Cells
Bone Marrow Immune Signatures in Multiple Myeloma Are Linked to Tumor Heterogeneity and Treatment Outcome
Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single‐cell transcriptomics
Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease
The Spatial Heterogeneity in Newly Diagnosed Multiple Myeloma Patients - from Sub-Clonal Architecture to the Immune Microenvironment
OAB-007: Single-cell multiomic analysis identifies regulatory programs in relapsed/refractory multiple myeloma
Targeting PI3K-AKT-mTOR Signaling in Multiple Myeloma Mesenchymal Stem Cells Mediates Antiproliferative Effect on Myeloma Cells
P-049: The spatial sub-clonal architecture in newly diagnosed myeloma patients revealed by whole genome and single-cell sequencing
P-060: Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single cell transcriptomics
HDP-101, an Anti-BCMA Antibody–Drug Conjugate, Safely Delivers Amanitin to Induce Cell Death in Proliferating and Resting Multiple Myeloma Cells
Comprehensive Comparison of Early Relapse and End-Stage Relapsed Refractory Multiple Myeloma
A Comprehensive Analysis of Single-Cell Chromatin Accessibility and Gene Expression Identifies Intra-Tumor Heterogeneity and Molecular Treatment Responses in Relapsed/Refractory Multiple Myeloma
Dissecting Heterogeneity of Tumor Cells and Their Microenvironment in Refractory Multiple Myeloma
HDP-101: Preclinical evaluation of a novel anti-BCMA antibody drug conjugates in multiple myeloma.
Preclinical Evaluation of Hdp-101, a Novel Anti-BCMA Antibody-Drug Conjugate, in Multiple Myeloma
IgE-dependent activation of human mast cells and fMLP-mediated activation of human eosinophils is controlled by the circadian clock
The circadian clock is functional in eosinophils and mast cells
Substantially Improved Outcome of Adult Burkitt Non-Hodgkin Lymphoma and Leukemia Patients with Rituximab and a Short-Intensive Chemotherapy; Report of a Large Prospective Multicenter Trial